⌘K

Login Start Free

Home/Filings/4/0001171843-15-001934

4//SEC Filing

Capstone Therapeutics Corp. 4

Accession 0001171843-15-001934

$CAPSCIK 0000887151operating

View on SEC.gov Company Profile

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 6:18 PM ET

Size

5.3 KB

Accession

0001171843-15-001934

Insider Transaction Report

Form 4

Period: 2015-04-10

Capstone Therapeutics Corp.CAPS

TAEGER LESLIE M

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2015-04-10+40,000→ 658,706 total
Exercise: $0.17From: 2015-04-10Exp: 2025-04-10→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]50% to vest 4/10/15 and 50% to vest monthly by 4/10/16

Documents

1 file

4
gff4_taeger041315.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Capstone Therapeutics Corp.

CIK 0000887151

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000887151

Filing Metadata

Form type: 4
Filed: Apr 12, 8:00 PM ET
Accepted: Apr 13, 6:18 PM ET
Size: 5.3 KB

View on SEC.gov